Sparks, the children’s medical research charity, and the Great Ormond Street Hospital (GOSH) Children’s Charity have launched a £2m joint national funding call to support paediatric health research studies focusing on complex or rare diseases.
The call is intended to support research across the spectrum of medical conditions affecting the foetus, neonates and children directly, as well as pregnancy disorders that affect the child. Applications for the 2020/21 funding round will also be considered for studies seeking to understand how COVID-19 affects children, particularly in the context of pre-existing diseases or conditions.
Grants of up to £250,000 over a maximum of three years are available to researchers across the UK. Applicants do not need to have a co-applicant or collaborator from Great Ormond Street Hospital or the UCL Great Ormond Street Institute of Child Health. Applications from early-career researchers and those still consolidating independent research careers are particularly encouraged.
All projects must aim to improve understanding of the disease or associated conditions or improve outcomes for the affected child and have the potential to lead to new medical developments, such as diagnostic tools or novel interventions, with a clear articulation of the route to clinical application through a combination of clinical and laboratory-based research.
For the 2020/21 funding call, Sparks and GOSH have partnered with Acrodysostosis Support and Research, Dravet Syndrome UK, Krabbe UK and the Myotubular Trust to offer possible joint awards for applications that address the following:
- Aim to improve the treatment or quality of life of patients with Acrodysostosis, particularly research into making a mouse model for Acrodysostosis Type 2, so that treatments can be found and tested using repurposed drugs.
- Improve understanding, quality of life for those affected by Dravet Syndrome including those that investigate and improve treatments in comorbidities associated with Dravet Syndrome.
- Aim to address the cause, diagnosis, understanding and treatment of Krabbe Disease.
- Aim to significantly advance the search to find a cure and/or a treatment for any of the genetic forms of centronuclear and myotubular myopathy, including studies on modifiers of disease progression.
Stage 1 applications should be submitted via the online application portal on the GOSH website by the closing date of 19 August 2020 (4pm).
Final funding decisions will be announced in April 2021.
More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.